Regulation of fatty acid biosynthesis as a possible mechanism for the mitoinhibitory effect of fumonisin B1 in primary rat hepatocytes

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 61, Issue 4, 1999, Pages 225-234

  Gelderblom, W C A ^b   Abel, S ^b   Smuts, C M ^b   Swanevelder, S ^a   Snyman, S D ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; EPIDERMAL GROWTH FACTOR; FATTY ACID; FUMONISIN B1; IBUPROFEN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LONG CHAIN FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; LIVER CELL CULTURE; MALE; MEMBRANE STRUCTURE; MITOGENESIS; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032696251     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.1999.0094     Document Type: Article

References (45)

1. Butterworth B. E., Goldsworthy T. L. The role of cell proliferation in multistage carcinogenesis. Proc Soc Exp Biol Med. 1991;683-687.
2. Farber E. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res. 55:1995;3759-3762.
3. Farber E. Hepatocyte proliferation in stepwise development of experimental liver cell cancer. Digest Disease Sci. 36:1991;973-978.
4. Coni P., Pichiri-Coni G., Curto M. Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model. Jpn J Cancer Res. 84:1993;501-507.
5. Farber E., Chen Z. Y., Harris L. The biochemicaL-molecular pathology of the stepwise development of liver cancer: new insights and problems. Bannasch P., Keppler D., Weber G. Liver Cell Carcinoma. 1989;273-291 Kluwer, Dordrecht.
6. Schulte-Hermann R., Grasl-Kraupp B., Bursch W. Apoptosis and hepatocarcinogenesis. Jirtle R. L. Liver Regeneration and Carcinogenesis. 1995;140-178 Academic Press, San Diego.
7. Chang W. L., Chapkin R. S., Lupton J. R. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis. 18:1997;721-730.
8. Bedi A., Pasricha P. J., Akhar A. J., Barber J. P., Bedi G. C., Giardiello F. M., Zehnbauer B. A., Hamilton S. R., Jones R. J. Inhibition of apoptosis during development of colerectal cancer. Cancer Res. 55:1995;1811-1816.
9. 1in rat liver using diethylnitrosamine as cancer initiator. Cancer Lett. 109:1996;101-108.
10. 1on rat hepatocytes in primary culture. Carcinogenesis. 16:1995;625-631.
11. Abbas H. K., Gelderblom W. C. A., Cawood M. E., Shier W. T. Biological activities of fumonisins, mycotoxins from Fusarium moniliforme, in Jimsonweed (Datura stramonium L.) and mammalian cell cultures. Toxicon. 31:1993;345-353.
12. Yoo H.-S., Norred W. P., Wang E., Merrill A. H., Riley R. T. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Pharmacol. 114:1992;9-15.
13. 1in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Carcinogenesis. 17:1996;239-249.
14. Wang E., Norred W. P., Bacon C. W., Riley R. T., Merrill A. H. Jr. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem. 266:1991;14,486-14,490.
15. Schroeder J. J., Crane H. M., Xia J. X., Liotta D. C., Merrill A. H. Jr. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J Biol Chem. 269:1994;3475-3481.
16. Ballou L. R., Laulederkind S. J. F., Rosloneic E. F., Raghow R. Ceramide signalling and the immune response. Biochem Biophys Acta. 1301:1996;272-287.
17. Merrill A. H. Sphingosine and other long-chain bases that alter cell behaviour. Curr Topics Membranes. 40:1994;361-386.
18. 1on protein and lipid synthesis in primary hepatocytes. Food Chem Toxicol. 34:1996;361-369.
19. Gelderblom W. C. A., Smuts C. M., Abel S., Snyman S. D., Van der Westhuizen L., Huber W. W., Swanevelder S. The effect of fumonisin B1 on the levels and fatty acid composition of selected lipids in rat liver in vivo. Food Chem Toxicol. 35:1997;647-656.
20. Gelderblom W. C. A., Snyman S. D., Abel S. Hepatotoxicity and carcinogenicity of the fumonisins in rats: a review regarding mechanistic implications for establishing risk in humans. Jackson L. S., de Vries J. W., Bullerman L. B. Fumonisins in Food. 1996;279-298 Plenum, New York.
21. Huang C., Dickman M., Hendeson G., Jones C. Repression of protein kinase C and stimulation of cylcic AMP response elements by fumonsin, a fungal encoded toxin which is a carcinogen. Cancer Res. 55:1995;1655-1659.
22. 1a mycotoxin. Biochem Biophys Commun. 220:1996;160-165.
23. 1liver tumorigenesis in rats. Proc Am Assoc Cancer Res. 38:1996;495.
24. 1. Biochem Biophys Res Commun. 227:1996;622-627.
25. Kaushal V., Barnes L. D. Effect of zwitterionic buffers on measurement of small masses of protein with bicinchoninic acid. Anal Biochem. 157:1986;291-294.
26. Rosenburg L., Palmer J. R., Warshauer M. E., Stolley S. S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 83:1991;355-358.
27. Hayes M. A., Roberts E., Roomi M. W., Safe S. H., Farber E., Cameron R. G. Comparative influences of different PB-type and 3-MC-type polychlorinated biphenyl-induced phenotypes on cytocidal hepatotoxicity of bromobenzene and acetaminophen. Toxicol Appl Pharmacol. 76:1984;118-127.
28. Cornwell D. G., Morisaki N. Fatty acid paradoxes in the control of cell proliferation: prostaglandins, lipid peroxides and co-oxidation reactions. Pryor W. A. Free Radicals in Biology VI. 1984;95-148 Academic Press, Orlando.
29. Marnett L. J. Aspirin and the potential of prostaglandins in colon cancer. Cancer Res. 52:1992;5575-5589.
30. Nolan R. D., Danilowics R. M., Eling T. E. Role of arachidonic acid metabolism in the mitogenic response of Balb/c 3T3 fibroblasts to Epidermal Growth Factor. Molec Pharmacol. 33:1988;650-656.
31. Handler J. A., Danilowics R. M., Eling T. E. Mitogenic signalling by epidermal growth factor (EGF), but not platelet-derived growth factor, requires arachidonic acid metabolism in BALB/c 3T3 cells. J Biol Chem. 265:1990;3669-3673.
32. Adachi T., Nakashima S., Saji S., Nakamura T., Nozawa Y. Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. Hepatology. 21:1995;1668-1674.
33. Adachi T., Nakashima S., Saji S., Nakamura T., Nozawa P. Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: involvement of protein tyrosine kinase and protein kinase C. Hepatology. 23:1996;1244-1453.
34. Whelan J., Broughton K. S., Surette M. E., Kinsella J. E. Dietary arachidonic and linoleic acids: comparative effects on tissue lipids. Lipids. 27:1992;85-88.
35. Horribin D. F. Nutrional and medical importance of gamma-linolenic acid. Prog Lipid Res. 31:1992;163-194.
36. Simopoulos A. P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 54:1991;438-463.
37. Horrobin D. F. Gamma linoleic acid: an intermediate in essential fatty acid metabolism with the potential as an ethical pharmaceutical and as a food. Rev Contemp Pharmacother. 1:1990;1-45.
38. 14C labelled fumonisin B mycotoxins with primary rat hepatocyte cultures. Food Chem Toxicol. 32:1994;627-632.
39. 1and other structurally related compounds. Food Chem Toxicol. 36:1998;497-503.
40. Japriya S., Linardic C. M., Hannun Y. A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α J Biol Chem. 269:1994;5757-5763.
41. Hhan W. A., Blobe G. C., Hannun Y. A. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cellular Signalling. 7:1995;171-184.
42. 1-induced rat hepatoma cells by glucocorticoids. Carcinogenesis. 19:1998;1191-1202.
43. De Kock M., Lottering M. L., Grobler C. J. S., Viljoen T. C., Le Roux M., Seegers J. C. The induction of apoptosis in human cervical carcinoma (Hela) cells by gamma-linolenic acid. Prostaghandins Leukot Essent Fatty Acids. 55:1996;403-411.
44. 1, a carcinogenic mycotoxin produced by Fusarium moniliforme. Carcinogenesis. 1999.
45. Bose R., Verheij M., Haimovitz-Friedman A., Scotto K., Fuks Z., Kolenski R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell. 82:1995;405-414.